These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1917165)

  • 1. Induction of multiple-drug resistance during anti-neoplastic chemotherapy in vitro.
    Licht T; Fiebig HH; Bross KJ; Herrmann F; Berger DP; Shoemaker R; Mertelsmann R
    Int J Cancer; 1991 Oct; 49(4):630-7. PubMed ID: 1917165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of vindesine and doxorubicin resistance in multidrug-resistant pleural mesothelioma cells by tumor necrosis factor-alpha.
    Licht T; Lübbert M; Martens C; Bross KJ; Fiebig HH; Mertelsmann R; Herrmann F
    Cytokines Mol Ther; 1995 Jun; 1(2):123-32. PubMed ID: 9384669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential emergence of distinct resistance phenotypes in murine erythroleukemia cells under adriamycin selection: decreased anthracycline uptake precedes increased P-glycoprotein expression.
    Slapak CA; Daniel JC; Levy SB
    Cancer Res; 1990 Dec; 50(24):7895-901. PubMed ID: 1979251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576.
    Mistry P; Stewart AJ; Dangerfield W; Okiji S; Liddle C; Bootle D; Plumb JA; Templeton D; Charlton P
    Cancer Res; 2001 Jan; 61(2):749-58. PubMed ID: 11212278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the MDR-1-encoded multiple drug resistance phenotype in prostate cancer cell lines.
    Theyer G; Schirmböck M; Thalhammer T; Sherwood ER; Baumgartner G; Hamilton G
    J Urol; 1993 Nov; 150(5 Pt 1):1544-7. PubMed ID: 8105110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Calcium antagonists as modulators of multi-drug resistant tumor cells].
    Hamilton G; Theyer G; Baumgartner G
    Wien Med Wochenschr; 1993; 143(19-20):526-32. PubMed ID: 7907828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
    David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
    Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of Vinca alkaloid resistance by anti-P-glycoprotein monoclonal antibody HYB-241 in a human tumor xenograft.
    Rittmann-Grauer LS; Yong MA; Sanders V; Mackensen DG
    Cancer Res; 1992 Apr; 52(7):1810-6. PubMed ID: 1348013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dominant expression of multiple drug resistance after in vitro X-irradiation exposure in intraspecific Chinese hamster ovary hybrid cells.
    McClean S; Hosking LK; Hill BT
    J Natl Cancer Inst; 1993 Jan; 85(1):48-53. PubMed ID: 8093217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined treatment of P-gp-positive L1210/VCR cells by verapamil and all-trans retinoic acid induces down-regulation of P-glycoprotein expression and transport activity.
    Sulová Z; Macejová D; Seres M; Sedlák J; Brtko J; Breier A
    Toxicol In Vitro; 2008 Feb; 22(1):96-105. PubMed ID: 17920233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
    Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
    Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of cytostatic drugs by nifedipine in two heterotransplanted human testicular-cancer cell lines differing in their sensitivity to standard agents.
    Bokemeyer C; Dunn T; Harstrick A; Lerch T; Poliwoda H; Schmoll HJ
    Int J Cancer; 1994 Feb; 56(3):452-6. PubMed ID: 7906255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidrug resistance gene 1 expression in salivary gland adenocarcinomas and oral squamous-cell carcinomas.
    Uematsu T; Hasegawa T; Hiraoka BY; Komatsu F; Matsuura T; Yamada AS; Yamaoka M
    Int J Cancer; 2001 Apr; 92(2):187-94. PubMed ID: 11291044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibody MRK16 reverses the multidrug resistance of multidrug-resistant transgenic mice.
    Mickisch GH; Pai LH; Gottesman MM; Pastan I
    Cancer Res; 1992 Aug; 52(16):4427-32. PubMed ID: 1353705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection of non-P-glycoprotein mediated high-level etoposide resistant cell lines by adriamycin with P-gp inhibitors.
    Ades S; Maxfield LF; Gould CJ; Jones GK; Levy SB
    Int J Oncol; 2006 Mar; 28(3):747-53. PubMed ID: 16465381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular targets in oncology: implications of the multidrug resistance gene.
    Lum BL; Gosland MP; Kaubisch S; Sikic BI
    Pharmacotherapy; 1993; 13(2):88-109. PubMed ID: 8097038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The anti-hepatitis drug DDB chemosensitizes multidrug resistant cancer cells in vitro and in vivo by inhibiting P-gp and enhancing apoptosis.
    Jin J; Sun H; Wei H; Liu G
    Invest New Drugs; 2007 Apr; 25(2):95-105. PubMed ID: 16937080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of multidrug resistance in vivo by dietary administration of the phytochemical indole-3-carbinol.
    Christensen JG; LeBlanc GA
    Cancer Res; 1996 Feb; 56(3):574-81. PubMed ID: 8564974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Over-expression of MDR1 gene with no DNA amplification in a multiple-drug-resistant human ovarian carcinoma cell line.
    Bénard J; Da Silva J; Teyssier JR; Riou G
    Int J Cancer; 1989 Mar; 43(3):471-7. PubMed ID: 2925277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical multi-drug resistance (MDR): low sensitivity of a P-glycoprotein-expressing human T lymphoblastoid MDR cell line to classical P-glycoprotein-directed resistance-modulating agents.
    Jachez B; Loor F
    Anticancer Drugs; 1993 Dec; 4(6):605-15. PubMed ID: 7905300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.